To study the potential involvement of senescence-associated phenomena in ALS, we explored the profile of senescence biomarkers, including the expression and protein levels of cell cycle modulators linked to mitosis arrest (p16 and p21). The gene discussed is CDKN2A; the disease is amyotrophic lateral sclerosis.